Abbott Diabetes Care, Inc. recalls Precision Xtra Blood Glucose & Ketone Monitoring System, UDI: 00093815715023, 00093815988144
- Recall date
- November 14, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1556-2020
- FDA classification
- Class II
- Brand / firm
- Abbott Diabetes Care, Inc.
- Sold / distributed
- U.S.: KY, NY, TN, MA, IL, SC, VT, FL, CA, NC, MS, NJ, TX, AL, GA, OK, CT, PA, NE, ND, MT, MO, DC, ME, LA, KS, ID, OH, MN, NM, VA, IN
Why it was recalled
Instructions sent in a letter or in instructions for use for disinfecting blood glucose and/or ketone meters were distributed but not cleared by the U.S. FDA, and devices were not cleared for multiple-patient use. Instructions could lead to inappropriate meter disinfection or improper handling of contaminated meters, which may cause infection or exacerbation of an existing infection.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Precision Xtra Blood Glucose & Ketone Monitoring System, UDI: 00093815715023, 00093815988144
Get recall alerts
Free email alert whenever Abbott Diabetes Care, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Abbott Diabetes Care, Inc.